|Bid||314.01 x 800|
|Ask||314.24 x 900|
|Day's Range||312.05 - 317.85|
|52 Week Range||242.00 - 355.88|
|Beta (3Y Monthly)||1.00|
|PE Ratio (TTM)||28.87|
|Forward Dividend & Yield||2.00 (0.65%)|
|1y Target Est||N/A|
Humana makes a strong showing in the Forbes Just 100, which ranks the nation's largest publicly traded companies that are "doing right by America."
Saturday, Dec. 15 is the last day most Americans can sign up for an Obamacare health plan if they want coverage at the first of the year.
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
In September, Humana announced that it would donate $15 million to the university over 10 years in order to unite the UH College of Medicine and the existing colleges of nursing, pharmacy, social work and optometry.
Humana Inc. named a new member to its C-suite and shifted oversight of a key division. Dr. Vishal Agrawal will be Humana's chief strategy and corporate development officer, starting Dec. 10, according to a news release. Agrawal will oversee Humana's "strategic insights and planning process, establishing direction for merger, acquisition and joint venture activities, while maximizing capabilities to create competitive advantage," according to the release.
A Kansas City pilot program appears to be the spark for talks that could result in the two health care giants taking equity stakes in each another.
Aetna enters a new phase in its history as it becomes a part of CVS (NYSE:CVS). Investors want to know how this dynamic will affect CVS stock. The dynamics that have brought Aetna and CVS together have manifested over decades.
On November 29, United Health Group’s (UNH) stock price closed at $282.55, which is ~8% growth from its close of $261.62 on November 23. United Health Group’s stock price increased from $220.46 to $282.55 when the market closed on November 29, which reflects ~28% YTD (year-to-date) growth. On November 29, United Health Group hit its 52-week high of $285.45.
PRA Health Sciences (PRAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Walgreens Boots Alliance Inc. CEO Stefano Pessina discussed his company's relationship with Humana at the 2018 Forbes Healthcare Summit.
About 10 months ago, Harris Corp. CEO Bill Brown and L3 Technologies Inc. CEO Chris Kubasik began talking about merging their two companies — something that ultimately would shake up the order of elite defense contractors. L3 knows Harris. After months of conversations and planning, the two companies’ boards approved the deal, an agreement was signed and the pending merger of equals was announced to the world Oct. 14.
Riding high on robust results, strong capital efficiency and buyouts; Anthem (ANTM) holds great prospects to reap returns for investors.
Humana Inc. is speeding up its buyback of $3 billion worth of company shares. The Louisville-based health insurance and care provider will repurchase $750 million of its common shares through an accelerated share repurchase agreement with Goldman Sachs & Co. LLC, a subsidiary of New York City-based investment bank and financial service titan Goldman Sachs Group Inc., according to a news release from Humana. The deal between Humana (NYSE: HUM) and Goldman Sachs was effective Wednesday, the day it was announced, according to a publicly available filing submitted to the Securities and Exchange Commission.